Functional Outcomes of The Bobath Approach on Patients With Brain Tumors: Comparison With Stroke Patients

NCT03574467 | Completed

• 1 other identifier: GO 18/25-13
• Study Type: observational
• Target: 32
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to examine the functional recovery results of the Bobath (NDT) approach in patients with primary brain tumors and compare the results with those of stroke patients.

Conditions

Brain Neoplasms; Stroke, Acute

Keywords

brain neoplasms; stroke; rehabilitation

Outcome Measures

Primary Outcomes (1)

• The Stroke Rehabilitation Assessment of Movement Measure (STREAM)

  The Stroke Rehabilitation Assessment of Movement Measure (STREAM) is a scale with scores ranging from 0 to 70, which is used to provide an understanding of the levels of movement and quality of hemiplegic patients.

  Patients were evaluated immediately before rehabilitation, and immediately after rehabilitation service, which lasted 4-10 days on average.

Secondary Outcomes (2)

• The Functional Independent Measurement (FIM)

  Patients were evaluated immediately before rehabilitation, and immediately after rehabilitation service, which lasted 4-10 days on average.

• Mini-Mental State Examination (MMSE)

  Patients were evaluated immediately before rehabilitation, and immediately after rehabilitation service, which lasted 4-10 days on average.

Study Arms (2)

Bobath Approach Applied to Patient with Brain Tumors

Behavioral: Bobath Neurodevelopmental Treatment Approach

Bobath Approach Applied to Patient with Stroke

Behavioral: Bobath Neurodevelopmental Treatment Approach

Interventions

Bobath Neurodevelopmental Treatment Approach BEHAVIORAL

The Bobath Neurodevelopmental Treatment (NDT) rehabilitation approach is effective in increasing the functional capacity and acquiring independence in patients with stroke and brain tumor.

Bobath Approach Applied to Patient with Brain Tumors; Bobath Approach Applied to Patient with Stroke

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Department of Neurology between June 2016 and April 2017, were analyzed for the study. The study inclusion criteria were determined for all patients to be over 18 years of age, in the acute phase, Glasgow Coma Scale score 14 and above, Modifiye Rankin Score being more than 2 and medical stability. Furthermore, the criteria for inclusion in the study were unilateral stroke and having a stroke for the first time for stroke patients, and supratentorial location for patients with brain tumors.

You may qualify if:

• acute phase patients with brain tumor and stroke in after surgery

You may not qualify if:

• Modified rankin scale \<2
• High grade tumor
• Infratentorial tumor
• GCS\<14
• Rehabilitation session time\<3
• Second or more tumor surgery
• Second or more stroke
• Bilateral stroke

Sponsors & Collaborators

• Hacettepe University: lead

Study Sites (1)

Hacettepe University

Ankara, Altındağ, 06511, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Brain Neoplasms; Stroke

Condition Hierarchy (Ancestors)

Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Cerebrovascular Disorders; Vascular Diseases; Cardiovascular Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: June 11, 2018
• First Posted: July 2, 2018
• Study Start: February 15, 2018
• Primary Completion: April 10, 2018
• Study Completion: June 12, 2018
• Last Updated: July 2, 2018

Record last verified: 2018-06

Locations

TU (1)